Iran drug stocks under two months, 800 medicines at risk as FX delays bite

Iran’s medicine and infant-formula stocks average less than two months, with as many as 800 drug lines at risk of shortage within three months, industry representatives said, citing four-to-five-month delays in foreign-exchange allocation.